2fsz: Difference between revisions

From Proteopedia
Jump to navigationJump to search
← Older editNewer edit →
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,331,613 edits
No edit summary
OCA (talk | contribs)
Bots, Bureaucrats, journal, Administrators
3,331,613 edits
No edit summary
Line 1: Line 1:
[[Image:2fsz.gif|left|200px]]
{{Seed}}
[[Image:2fsz.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2fsz|  PDB=2fsz  |  SCENE=  }}  
{{STRUCTURE_2fsz|  PDB=2fsz  |  SCENE=  }}  


'''A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta'''
===A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta===




==Overview==
<!--  
Evidence is presented that the estrogen antagonist 4-hydroxytamoxifen (HT) can occupy not only the core binding pocket within the ligand-binding domain of estrogen receptor (ER) beta but also a second site on its surface. The crystal structure of the ligand-binding domain (LBD) associated with HT was determined to 2.2 A and revealed two molecules of HT bound to the protein. One was located in the consensus ligand-binding pocket, whereas the other bound to a site that overlaps with the hydrophobic groove of the coactivator recognition surface. Relative to the ERalpha-tamoxifen structure, helix 12 has been displaced from the coactivator recognition surface and occupies a unique position. Although it has been demonstrated that association of the antagonist with the core ligand-binding pocket is sufficient to induce an antagonist ligand-binding domain conformation, this structure suggests that small molecules may directly antagonize receptor-coactivator interactions. These results provide a direct demonstration of two binding sites for HT in ERbeta, as has been previously suggested for ERalpha by using biochemical methods, and represent a crystal structure of a small nonpeptide molecule occupying the coactivator recognition site.
The line below this paragraph, {{ABSTRACT_PUBMED_16782818}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 16782818 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_16782818}}


==About this Structure==
==About this Structure==
Line 24: Line 28:
[[Category: Wang, Yong]]
[[Category: Wang, Yong]]
[[Category: Nuclear hormone binding domain]]
[[Category: Nuclear hormone binding domain]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 04:16:46 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 13:44:08 2008''

Revision as of 10:44, 29 July 2008

File:2fsz.png

Template:STRUCTURE 2fsz

A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta

Template:ABSTRACT PUBMED 16782818

About this Structure

2FSZ is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

Reference

A second binding site for hydroxytamoxifen within the coactivator-binding groove of estrogen receptor beta., Wang Y, Chirgadze NY, Briggs SL, Khan S, Jensen EV, Burris TP, Proc Natl Acad Sci U S A. 2006 Jun 27;103(26):9908-11. Epub 2006 Jun 16. PMID:16782818

Page seeded by OCA on Tue Jul 29 13:44:08 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "https://proteopedia.org/index.php?title=2fsz&oldid=743692"